KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Research & Development: 2009-2024

Historic Research & Development for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to $3.6 billion.

  • Vertex Pharmaceuticals' Research & Development rose 11.62% to $977.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 13.84%. This contributed to the annual value of $3.6 billion for FY2024, which is 14.78% up from last year.
  • As of FY2024, Vertex Pharmaceuticals' Research & Development stood at $3.6 billion, which was up 14.78% from $3.2 billion recorded in FY2023.
  • Vertex Pharmaceuticals' 5-year Research & Development high stood at $3.6 billion for FY2024, and its period low was $1.6 billion during FY2020.
  • Over the past 3 years, Vertex Pharmaceuticals' median Research & Development value was $3.2 billion (recorded in 2023), while the average stood at $3.1 billion.
  • In the last 5 years, Vertex Pharmaceuticals' Research & Development decreased by 6.25% in 2020 and then soared by 31.09% in 2022.
  • Yearly analysis of 5 years shows Vertex Pharmaceuticals' Research & Development stood at $1.6 billion in 2020, then increased by 17.81% to $1.9 billion in 2021, then surged by 31.09% to $2.5 billion in 2022, then climbed by 24.51% to $3.2 billion in 2023, then increased by 14.78% to $3.6 billion in 2024.